Neuraxis (NRXS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $7.74, +18.53% vs the prior close of $6.53.
- Volume 1.13M shares, 9.8x its 50-day average (heavy).
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
NRXS jumps 18.5% to $7.74 on 9.8x normal volume. Closed at $7.74, +18.53% vs the prior close of $6.53. Day range $6.80–$7.84, opened at $6.87.
NRXS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NRXS jumps 18.5% to $7.74 on 9.8x normal volume
- Closed at $7.74, +18.53% vs the prior close of $6.53. Day range $6.80–$7.84, opened at $6.87.
- Volume was 1.13M shares, 9.8x its 50-day average of 115.07K — unusually heavy trading.
- Price is +17.3% vs its 50-day average ($6.60) and +19.0% vs its 200-day average ($6.51).
- 52-week range $2.21–$9.33; today's close sits at 78% of that range, 17.0% below the 52-week high.
Oct 14, 2026 — NRXS rises 0.5% to $6.53
- Closed at $6.53, +0.46% vs the prior close of $6.50. Day range $6.00–$6.64, opened at $6.44.
- Volume was 173.10K shares, 1.5x its 50-day average of 114.80K.
- Price is -0.7% vs its 50-day average ($6.58) and +0.6% vs its 200-day average ($6.49).
- 52-week range $2.21–$9.33; today's close sits at 61% of that range, 30.0% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — NRXS slides 3.3% to $6.50
- Closed at $6.50, -3.27% vs the prior close of $6.72. Day range $6.40–$6.75, opened at $6.65.
- Volume was 117.90K shares, 1.0x its 50-day average of 114.02K.
- Price is -1.3% vs its 50-day average ($6.59) and +0.4% vs its 200-day average ($6.48).
- 52-week range $2.21–$9.33; today's close sits at 60% of that range, 30.3% below the 52-week high.
Oct 12, 2026 — NRXS slides 3.0% to $6.72
- Closed at $6.72, -3.03% vs the prior close of $6.93. Day range $6.55–$6.86, opened at $6.86.
- Volume was 74.60K shares, 0.7x its 50-day average of 113.38K.
- Price is +2.0% vs its 50-day average ($6.59) and +4.0% vs its 200-day average ($6.46).
- 52-week range $2.21–$9.33; today's close sits at 63% of that range, 28.0% below the 52-week high.
Oct 9, 2026 — NRXS rises 2.4% to $6.93
- Closed at $6.93, +2.36% vs the prior close of $6.77. Day range $6.79–$7.05, opened at $6.96.
- Volume was 56.70K shares, 0.5x its 50-day average of 115.57K — lighter than usual.
- Price is +5.3% vs its 50-day average ($6.58) and +7.5% vs its 200-day average ($6.45).
- 52-week range $2.21–$9.33; today's close sits at 66% of that range, 25.7% below the 52-week high.
Oct 8, 2026 — NRXS dips 0.9% to $6.77
- Closed at $6.77, -0.88% vs the prior close of $6.83. Day range $6.67–$6.99, opened at $6.81.
- Volume was 30.00K shares, 0.3x its 50-day average of 118.25K — lighter than usual.
- Price is +3.1% vs its 50-day average ($6.57) and +5.3% vs its 200-day average ($6.43).
- 52-week range $2.21–$9.33; today's close sits at 64% of that range, 27.4% below the 52-week high.
Oct 7, 2026 — NRXS rises 0.7% to $6.83
- Closed at $6.83, +0.74% vs the prior close of $6.78. Day range $6.60–$7.03, opened at $6.72.
- Volume was 66.10K shares, 0.6x its 50-day average of 118.75K — lighter than usual.
- Price is +4.2% vs its 50-day average ($6.55) and +6.5% vs its 200-day average ($6.41).
- 52-week range $2.21–$9.33; today's close sits at 65% of that range, 26.8% below the 52-week high.
Oct 6, 2026 — NRXS slides 5.2% to $6.78
- Closed at $6.78, -5.17% vs the prior close of $7.15. Day range $6.76–$7.31, opened at $7.20.
- Volume was 66.50K shares, 0.6x its 50-day average of 119.63K — lighter than usual.
- Price is +3.6% vs its 50-day average ($6.55) and +6.0% vs its 200-day average ($6.39).
- 52-week range $2.21–$9.33; today's close sits at 64% of that range, 27.3% below the 52-week high.
Oct 5, 2026 — NRXS rises 0.6% to $7.15
- Closed at $7.15, +0.56% vs the prior close of $7.11. Day range $7.07–$7.40, opened at $7.15.
- Volume was 53.80K shares, 0.5x its 50-day average of 119.29K — lighter than usual.
- Price is +9.2% vs its 50-day average ($6.55) and +12.2% vs its 200-day average ($6.37).
- 52-week range $2.21–$9.33; today's close sits at 69% of that range, 23.4% below the 52-week high.
Oct 2, 2026 — NRXS dips 0.8% to $7.11, 3 down days in a row
- Closed at $7.11, -0.84% vs the prior close of $7.17. Day range $7.01–$7.49, opened at $7.26.
- Volume was 47.40K shares, 0.4x its 50-day average of 119.22K — lighter than usual.
- Price is +8.7% vs its 50-day average ($6.54) and +11.9% vs its 200-day average ($6.35).
- 52-week range $2.21–$9.33; today's close sits at 69% of that range, 23.8% below the 52-week high.
- That makes 3 straight losses.
NRXS latest news & SEC filings
Every SEC filing by or about NRXS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carrico Brian Allen bought 268 shares at $4.84 (≈$1.30K) on Oct 8, 2026; now holds 227,604
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carrico Thomas Joeseph bought 328 shares at $4.84 (≈$1.59K) on Oct 8, 2026; now holds 199,673
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Henrichs Timothy Robert bought 1,937 shares at $4.84 (≈$9.38K) on Oct 8, 2026; now holds 9,530
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.93M (prior year $894.09K) (+115.7% vs Jun 30, 2025)
- Net income: -$2.09M (prior year -$1.69M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.19 (prior year -$0.22) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 3, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 10, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade NRXS
- Last results release: Apr 21, 2026 (8-K Item 2.02). Previous ones: Oct 23, 2025, Jan 8, 2025, Nov 12, 2024. Based on that rhythm, the next report is likely around Jul 21, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.39% (largest 18.5%). That is a volatile stock.
- Liquidity: about 147.46K shares (≈$1.14M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.74 vs a range of $2.21–$9.33 (78% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 6 open-market buys, 0 sales; latest: Brian Allen Carrico bought 8,060 shares on Apr 1, 2026.
- Latest filings: 8-K Oct 14, 2026; 8-K Aug 19, 2026; 10-Q Aug 11, 2026.
- Share count: 12.56M shares outstanding (Aug 6, 2026), +27.4% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Electromedical & Electrotherapeutic Apparatus.
NRXS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 6.87 | 7.84 | 6.80 | 7.74 | 1.13M |
| Oct 14, 2026 | 6.44 | 6.64 | 6.00 | 6.53 | 173.10K |
| Oct 13, 2026 | 6.65 | 6.75 | 6.40 | 6.50 | 117.90K |
| Oct 12, 2026 | 6.86 | 6.86 | 6.55 | 6.72 | 74.60K |
| Oct 9, 2026 | 6.96 | 7.05 | 6.79 | 6.93 | 56.70K |
| Oct 8, 2026 | 6.81 | 6.99 | 6.67 | 6.77 | 30.00K |
| Oct 7, 2026 | 6.72 | 7.03 | 6.60 | 6.83 | 66.10K |
| Oct 6, 2026 | 7.20 | 7.31 | 6.76 | 6.78 | 66.50K |
| Oct 5, 2026 | 7.15 | 7.40 | 7.07 | 7.15 | 53.80K |
| Oct 2, 2026 | 7.26 | 7.49 | 7.01 | 7.11 | 47.40K |
| Oct 1, 2026 | 7.39 | 7.95 | 7.00 | 7.17 | 134.90K |
| Sep 30, 2026 | 7.81 | 7.98 | 7.28 | 7.37 | 81.20K |
| Sep 29, 2026 | 7.53 | 8.05 | 7.50 | 7.76 | 102.80K |
| Sep 28, 2026 | 7.56 | 7.68 | 7.28 | 7.40 | 63.90K |
| Sep 25, 2026 | 7.69 | 7.99 | 7.56 | 7.56 | 144.40K |
| Sep 24, 2026 | 7.30 | 7.75 | 7.15 | 7.75 | 117.30K |
| Sep 23, 2026 | 7.32 | 7.53 | 6.94 | 7.31 | 58.00K |
| Sep 22, 2026 | 7.20 | 7.56 | 7.13 | 7.31 | 149.60K |
| Sep 21, 2026 | 7.69 | 7.69 | 7.11 | 7.14 | 110.80K |
| Sep 18, 2026 | 7.67 | 7.81 | 7.37 | 7.61 | 174.50K |
About Neuraxis
Neuraxis (NRXS) is listed on the NYSE and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in CARMEL, IN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1933567.
NRXS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gil Aharon | Director | Aug 17, 2026 |
| Brian Allen Carrico | Chief Executive Officer | Aug 26, 2026 |
| Kristin A Ferge | Director | Aug 17, 2026 |
| Jane Elizabeth Keyser | Director | Aug 17, 2026 |
| Bradley Mitchell Watkins | Director | Aug 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Craig Thomas Blanchard | Chief Commercial Officer | Sep 29, 2026 |
| Brian Allen Carrico | Chief Executive Officer | Aug 26, 2026 |
| Thomas Joeseph Carrico | CRO, CCO, CPO | Aug 26, 2026 |
| Timothy Robert Henrichs | Chief Financial Officer | Aug 17, 2026 |
| Adrian Miranda | CMO, SVP Science & Tech | Aug 26, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 1, 2026 | Brian Allen Carrico | Buy | 8,060 | $1.96 |
| Apr 1, 2026 | Thomas Joeseph Carrico | Buy | 667 | $1.96 |
| Apr 1, 2026 | Timothy Robert Henrichs | Buy | 7,593 | $1.96 |
| Feb 12, 2026 | Brian Hannasch | Buy | 40,000 | $4.92 |
| Feb 11, 2026 | Brian Hannasch | Buy | 40,000 | $4.65 |
| Dec 23, 2025 | Gil Aharon | Buy | 286,138 | $3.52 |
NRXS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.57M | $-7.80M | -0.95 | $-6.43M |
| Dec 31, 2024 | $2.69M | $-8.24M | -1.22 | $-6.10M |
| Dec 31, 2023 | $2.46M | $-14.63M | -4.50 | $-6.69M |
| Dec 31, 2022 | $2.68M | $-4.78M | -2.77 | $-2.30M |
Latest balance sheet: total assets $10.00M, total liabilities $3.26M, cash $8.32M (as of Jun 30, 2026).
NRXS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 21, 2026 | 8-K Item 2.02 (results) | $7.28 |
| Oct 23, 2025 | 8-K Item 2.02 (results) | $3.82 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $2.49 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $3.16 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| Apr 9, 2024 | 8-K Item 2.02 (results) | — |
| Sep 21, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)TransMedics (TMDX)Integer (ITGR)LivaNova (LIVN)Axogen (AXGN)Ceribell (CBLL)Conmed (CNMD)InMode (INMD)Electromed (ELMD)CapsoVision (CV)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NRXS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.